FY2023โFY2026 ยท from SEC filings ยท hover any figure for its source
$22.9M
โ$2.1M
2023
$22.6M
โ$4.5M
2024
$22.6M
$4.5M
2025
$20.5M
$3.5M
2026
RevenueNet income โ beside revenue when positive, below the line when a loss
Metric
FY2023
FY2024
FY2025
FY2026
Income statement
Revenue
$22,922,654
$22,603,845
$22,603,845
$20,504,221
Cost of goods sold
$4,382,031
$4,280,018
$4,280,018
$4,032,378
Gross margin
81%
81%
81%
80%
Net income
-$2,112,656
-$4,487,418
$4,487,418
$3,474,071
Taxes paid
$0
$0
$0
$0
Balance sheet
Cash
$4,877,482
$2,266,229
$2,266,229
$1,576,298
Accounts receivable
$9,850,359
$9,558,813
$9,558,813
$9,259,762
Total assets
$35,144,220
$32,597,198
$32,597,198
$37,851,528
Short-term debt
$0
$0
$0
$0
Long-term debt
$0
$1,645,319
$1,645,319
$5,908,549
Total liabilities
$0
$1,645,319
$1,645,319
$5,908,549
Other
Headcount
โ
46
โ
41
Figures as reported by the issuer in the filing shown on hover. Each yearโs pill shows the assurance level of its filed statements โ audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didnโt state one. Headcount is the filingโs point-in-time count, not a year-end average. Manually corrected figures are marked โCorrectedโ.
Source: SEC EDGARCIK 0001914262DEShare price $1.00Last synced Aug 17, 2026
About this data. Figures are compiled from public sources โ SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages โ and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.